NHI-2
Product Specifications
CAS Number
1269802-97-2
Target
Apoptosis|||Dehydrogenase
Related Pathways
Apoptosis|||Metabolism
Purity
0.9998
Bioactivity
NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 value of 14.7 µM, demonstrating high selectivity for LDHA over LDHB, for which the IC50 is 55.8 µM. NHI-2 functions as an efficient anti-glycolytic agent, enhancing apoptosis, inducing cell cycle arrest at the S and G2 phases, and exerting broad-spectrum antiproliferative effects in cancer cells. NHI-2 additionally affects extracellular acidification rates and ATP production and has demonstrated tumor growth suppression in murine B78 melanoma models, highlighting its role in cancer metabolism research.
Smiles
C(F)(F)(F)C1=C2C(N(O)C(C(OC)=O)=C2)=CC(=C1)C3=CC=CC=C3
Molecular Formula
C17H12F3NO3
Molecular Weight
335.28
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1202895-01 0.02 mg (E-Coli)
Recombinant Coffea arabica Photosystem II reaction center protein K (psbK)
Ask
View Details